Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands

Maria A. Siracusa, Loredana Salerno, Maria N. Modica, Valeria Pittalà, Giuseppe Romeo, Maria E. Amato, Mateusz Nowak, Andrzej J. Bojarski, Ilario Mereghetti, Alfredo Cagnotto, Tiziana Mennini

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

A series of new compounds containing a benzimidazole, benzothiazole, or benzoxazole nucleus linked to an arylpiperazine by different thioalkyl chains was prepared. They were tested in radioligand binding experiments to evaluate their affinity for 5-HT1A and 5-HT2A serotonergic, α1 adrenergic, D1, and D2 dopaminergic receptors. Many of tested compounds showed an interesting binding profile; in particular, 36 displayed very high 5-HT1A receptor affinity and selectivity over all the other investigated receptors. Selected compounds, evaluated in functional assays, showed antagonistic or partial agonistic activity at 5-HT1A receptor. An extensive conformational research using both NMR and modeling techniques indicated that extended conformations predominated in vacuum, in solution and during interactions with 5-HT 1A receptor. Finally, the elaborated binding mode of selected compounds at 5-HT1A receptor was used to explain the influence of spacer length on ligands affinity.

Original languageEnglish
Pages (from-to)4529-4538
Number of pages10
JournalJournal of Medicinal Chemistry
Volume51
Issue number15
DOIs
Publication statusPublished - Aug 14 2008

Fingerprint

Benzoxazoles
Receptor, Serotonin, 5-HT1A
Ligands
Derivatives
Vacuum
Adrenergic Agents
Conformations
Assays
Nuclear magnetic resonance
benzothiazole
Research
Experiments

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. / Siracusa, Maria A.; Salerno, Loredana; Modica, Maria N.; Pittalà, Valeria; Romeo, Giuseppe; Amato, Maria E.; Nowak, Mateusz; Bojarski, Andrzej J.; Mereghetti, Ilario; Cagnotto, Alfredo; Mennini, Tiziana.

In: Journal of Medicinal Chemistry, Vol. 51, No. 15, 14.08.2008, p. 4529-4538.

Research output: Contribution to journalArticle

Siracusa, MA, Salerno, L, Modica, MN, Pittalà, V, Romeo, G, Amato, ME, Nowak, M, Bojarski, AJ, Mereghetti, I, Cagnotto, A & Mennini, T 2008, 'Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands', Journal of Medicinal Chemistry, vol. 51, no. 15, pp. 4529-4538. https://doi.org/10.1021/jm800176x
Siracusa, Maria A. ; Salerno, Loredana ; Modica, Maria N. ; Pittalà, Valeria ; Romeo, Giuseppe ; Amato, Maria E. ; Nowak, Mateusz ; Bojarski, Andrzej J. ; Mereghetti, Ilario ; Cagnotto, Alfredo ; Mennini, Tiziana. / Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 15. pp. 4529-4538.
@article{2c169f64b1e24ad7a5c597f2277b358d,
title = "Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands",
abstract = "A series of new compounds containing a benzimidazole, benzothiazole, or benzoxazole nucleus linked to an arylpiperazine by different thioalkyl chains was prepared. They were tested in radioligand binding experiments to evaluate their affinity for 5-HT1A and 5-HT2A serotonergic, α1 adrenergic, D1, and D2 dopaminergic receptors. Many of tested compounds showed an interesting binding profile; in particular, 36 displayed very high 5-HT1A receptor affinity and selectivity over all the other investigated receptors. Selected compounds, evaluated in functional assays, showed antagonistic or partial agonistic activity at 5-HT1A receptor. An extensive conformational research using both NMR and modeling techniques indicated that extended conformations predominated in vacuum, in solution and during interactions with 5-HT 1A receptor. Finally, the elaborated binding mode of selected compounds at 5-HT1A receptor was used to explain the influence of spacer length on ligands affinity.",
author = "Siracusa, {Maria A.} and Loredana Salerno and Modica, {Maria N.} and Valeria Pittal{\`a} and Giuseppe Romeo and Amato, {Maria E.} and Mateusz Nowak and Bojarski, {Andrzej J.} and Ilario Mereghetti and Alfredo Cagnotto and Tiziana Mennini",
year = "2008",
month = "8",
day = "14",
doi = "10.1021/jm800176x",
language = "English",
volume = "51",
pages = "4529--4538",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "15",

}

TY - JOUR

T1 - Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands

AU - Siracusa, Maria A.

AU - Salerno, Loredana

AU - Modica, Maria N.

AU - Pittalà, Valeria

AU - Romeo, Giuseppe

AU - Amato, Maria E.

AU - Nowak, Mateusz

AU - Bojarski, Andrzej J.

AU - Mereghetti, Ilario

AU - Cagnotto, Alfredo

AU - Mennini, Tiziana

PY - 2008/8/14

Y1 - 2008/8/14

N2 - A series of new compounds containing a benzimidazole, benzothiazole, or benzoxazole nucleus linked to an arylpiperazine by different thioalkyl chains was prepared. They were tested in radioligand binding experiments to evaluate their affinity for 5-HT1A and 5-HT2A serotonergic, α1 adrenergic, D1, and D2 dopaminergic receptors. Many of tested compounds showed an interesting binding profile; in particular, 36 displayed very high 5-HT1A receptor affinity and selectivity over all the other investigated receptors. Selected compounds, evaluated in functional assays, showed antagonistic or partial agonistic activity at 5-HT1A receptor. An extensive conformational research using both NMR and modeling techniques indicated that extended conformations predominated in vacuum, in solution and during interactions with 5-HT 1A receptor. Finally, the elaborated binding mode of selected compounds at 5-HT1A receptor was used to explain the influence of spacer length on ligands affinity.

AB - A series of new compounds containing a benzimidazole, benzothiazole, or benzoxazole nucleus linked to an arylpiperazine by different thioalkyl chains was prepared. They were tested in radioligand binding experiments to evaluate their affinity for 5-HT1A and 5-HT2A serotonergic, α1 adrenergic, D1, and D2 dopaminergic receptors. Many of tested compounds showed an interesting binding profile; in particular, 36 displayed very high 5-HT1A receptor affinity and selectivity over all the other investigated receptors. Selected compounds, evaluated in functional assays, showed antagonistic or partial agonistic activity at 5-HT1A receptor. An extensive conformational research using both NMR and modeling techniques indicated that extended conformations predominated in vacuum, in solution and during interactions with 5-HT 1A receptor. Finally, the elaborated binding mode of selected compounds at 5-HT1A receptor was used to explain the influence of spacer length on ligands affinity.

UR - http://www.scopus.com/inward/record.url?scp=49449095466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449095466&partnerID=8YFLogxK

U2 - 10.1021/jm800176x

DO - 10.1021/jm800176x

M3 - Article

C2 - 18598015

AN - SCOPUS:49449095466

VL - 51

SP - 4529

EP - 4538

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 15

ER -